JPMorgan Chase & Co’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-142,854
| Closed | -$2.54M | – | 5094 |
|
|
2018
Q3 | $2.54M | Buy |
142,854
+129,556
| +974% | +$2.3M | ﹤0.01% | 2658 |
|
|
2018
Q2 | $183K | Buy |
+13,298
| New | +$183K | ﹤0.01% | 3854 |
|
|
2017
Q4 | – | Sell |
-53,778
| Closed | -$73K | – | 4802 |
|
|
2017
Q3 | $73K | Sell |
53,778
-188,688
| -78% | -$256K | ﹤0.01% | 3722 |
|
|
2017
Q2 | $364K | Sell |
242,466
-368,577
| -60% | -$553K | ﹤0.01% | 3246 |
|
|
2017
Q1 | $1.57M | Sell |
611,043
-178,692
| -23% | -$459K | ﹤0.01% | 2708 |
|
|
2016
Q4 | $2.01M | Buy |
789,735
+68,060
| +9% | +$174K | ﹤0.01% | 2671 |
|
|
2016
Q3 | $2.23M | Sell |
721,675
-60,810
| -8% | -$188K | ﹤0.01% | 2412 |
|
|
2016
Q2 | $2.51M | Buy |
782,485
+779,900
| +30,170% | +$2.5M | ﹤0.01% | 2348 |
|
|
2016
Q1 | $8K | Buy |
+2,585
| New | +$8K | ﹤0.01% | 3804 |
|
|
2013
Q4 | – | Sell |
-23,245
| Closed | -$310K | – | 3868 |
|
|
2013
Q3 | $310K | Sell |
23,245
-10,400
| -31% | -$139K | ﹤0.01% | 3515 |
|
|
2013
Q2 | $442K | Buy |
+33,645
| New | +$442K | ﹤0.01% | 3259 |
|